||||||||||basimglurant (NOE-101) / Noema Pharma Trial completion: A Study With RO4917523 in Patients With Fragile X Syndrome (clinicaltrials.gov) - Oct 13, 2011 P2, N=40, Completed, Sponsor: Hoffmann-La Roche N=32 --> 40 Active, not recruiting --> Completed